Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia.
Margherita FabbriMaurizio ZibettiGiovanna Calandra-BuonauraManuela ContinLuisa SambatiSusan MohamedAlberto RomagnoloPaola BerchiallaGabriele ImbalzanoGiulia GianniniMario G RizzoneCarlo Alberto ArtusiPietro CortelliLeonardo LopianoPublished in: Movement disorders clinical practice (2020)
Dyskinesia should be carefully monitored in patients undergoing LCIG, with particular caution for female patients. Whether combined clinical and pharmacodynamic assessments could be helpful to manage patients with troublesome dyskinesia under LCIG treatment needs further evaluation in a larger group of patients.